The University of Chicago Header Logo

Connection

Bakhtiar Yamini to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Bakhtiar Yamini has written about Xenograft Model Antitumor Assays.
Bakhtiar Yamini
Connection Strength
0.541
Xenograft Model Antitumor Assays
  1. Temozolomide Treatment Induces lncRNA MALAT1 in an NF-?B and p53 Codependent Manner in Glioblastoma. Cancer Res. 2019 05 15; 79(10):2536-2548.
    View in: PubMed
    Score: 0.144
  2. BCL3 expression promotes resistance to alkylating chemotherapy in gliomas. Sci Transl Med. 2018 07 04; 10(448).
    View in: PubMed
    Score: 0.137
  3. Decoy Receptor DcR1 Is Induced in a p50/Bcl3-Dependent Manner and Attenuates the Efficacy of Temozolomide. Cancer Res. 2015 May 15; 75(10):2039-48.
    View in: PubMed
    Score: 0.109
  4. Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. Nanomedicine. 2014 Jan; 10(1):149-57.
    View in: PubMed
    Score: 0.097
  5. Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma. Cancer Res. 2004 Sep 15; 64(18):6381-4.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.